The <scp>MIR181A2HG</scp>/<scp>miR</scp>‐5680/<scp>VCAN</scp>‐<scp>CD44</scp> Axis Regulates Gastric Cancer Lymph Node Metastasis by Promoting <scp>M2</scp> Macrophage Polarization

Weijie Zang, Yongpu Yang, Junjie Chen, Qin‐Sheng Mao, Wanjiang Xue, Yilin HuCancer 2025 · DOI

TL;DR

This study uncovers a novel molecular axis, MIR181A2HG/miR-5680/VCAN/CD44, that drives gastric cancer (GC) lymph node metastasis by promoting M2 macrophage polarization. This axis creates a positive feedback loop, suggesting MIR181A2HG as a promising therapeutic target for GC.

What Problem Does This Paper Address?

Gastric cancer (GC) is a significant global health concern, with a high mortality rate often attributed to tumor metastasis and recurrence. Lymphatic metastasis, in particular, is a major driver of poor prognosis. While lymphangiogenesis (the formation of new lymphatic vessels) is known to be crucial for this process, the precise molecular mechanisms, especially those involving tumor-associated macrophages (TAMs) and long non-coding RNAs (lncRNAs), remain largely elusive. This paper aims to elucidate the role of a specific lncRNA, MIR181A2HG, in GC lymph node metastasis and its underlying mechanisms.

Methods

The researchers employed a multi-faceted approach combining bioinformatics analysis, cell culture experiments, and in vivo models. Key techniques included:

  • Bioinformatics Screening: Identifying MIR181A2HG as differentially expressed in GC using TCGA and GEO databases.
  • Molecular Biology Techniques:
    • qRT-PCR: Quantifying gene and miRNA expression.
  • Immunofluorescence and Immunohistochemistry (IHC): Visualizing protein expression and cellular markers (e.g., CD163 for M2 macrophages, D2-40 and LYVE-1 for lymphatic vessels).
  • Western Blot: Detecting protein levels.
  • ELISA: Measuring protein concentrations in cell culture supernatants.
  • Luciferase Reporter Assays: Verifying interactions between RNA molecules and promoter regions.
  • RNA Pulldown and Co-Immunoprecipitation (Co-IP): Confirming direct binding between RNA and proteins.
  • RNA Interference (siRNA): Knocking down gene expression to study functional consequences.
  • Functional Assays:
    • Tube Formation and Transwell Assays: Assessing lymphangiogenesis, migration, and invasion of lymphatic endothelial cells (HLECs).
  • Macrophage Polarization Assays: Differentiating and analyzing macrophage phenotypes (M1 vs. M2).
  • In Vivo Models:
    • Popliteal Lymphatic Metastasis Model in Nude Mice: Evaluating the impact of MIR181A2HG on lymph node metastasis.

Datasets

  • TCGA STAD (Stomach Adenocarcinoma) Database: Used for analyzing MIR181A2HG expression, its correlation with prognosis, and transcription factor binding.
  • GEO Datasets (GSE109476 and GSE54129): Utilized for differential gene expression analysis of lncRNAs in GC.
  • Online Databases:
    • LncLocator: For predicting lncRNA subcellular localization.
  • LncBase V2: For predicting downstream miRNAs of MIR181A2HG.
  • TargetMiner, RNA22, DIANA-microT-CDS, TargetScan, MultiMIR: For predicting miRNA target genes.
  • Genecard: For identifying macrophage-related genes.
  • STRING, GeneMANIA, Hitpredict, Biogrid, Hint: For predicting protein-protein interactions.
  • HumanTFDB, PAZAR, GTRD, TRANSFAC, HTFtarget, JASPAR: For predicting transcription factor binding sites.

Key Insights and Ideas

  • MIR181A2HG as a Master Regulator: The study identifies MIR181A2HG as a key lncRNA that is significantly upregulated in GC and directly promotes lymph node metastasis.
  • The ceRNA Axis: MIR181A2HG acts as a competing endogenous RNA (ceRNA) by sponging miR-5680, leading to the upregulation of its target gene, VCAN. This is a crucial mechanism for its downstream effects.
  • VCAN's Dual Role: VCAN plays a critical role by interacting with CD44 on both macrophages (paracrine) and GC cells (autocrine), driving M2 macrophage polarization and activating the Hippo pathway, respectively.
  • M2 Macrophages as Key Effectors: The study strongly implicates M2-polarized macrophages, induced by the MIR181A2HG axis, as central players in promoting lymphangiogenesis and subsequent metastasis via VEGF-C secretion.
  • Positive Feedback Loop: A sophisticated positive feedback loop is established where VCAN, through CD44 and the Hippo pathway, upregulates SP1, which in turn drives MIR181A2HG transcription, perpetuating the metastatic process.

Key Results

  • MIR181A2HG expression was significantly higher in GC tissues compared to normal tissues and correlated with advanced TNM stage, lymph node metastasis, and higher microlymphatic vessel density (MLVD).
  • Knockdown of MIR181A2HG in GC cells significantly inhibited popliteal lymphatic metastasis in a mouse model, reducing tumor volume and weight of metastatic lymph nodes.
  • MIR181A2HG promoted M2 macrophage polarization (indicated by increased CD163 and IL-10 expression) and suppressed M1 polarization (decreased iNOS, IL-6, and TNF-α).
  • VCAN was identified as a direct target of miR-5680, and its expression was inversely correlated with miR-5680.
  • VCAN significantly promoted M2 macrophage polarization and VEGF-C secretion, which in turn enhanced HLEC tube formation, migration, and invasion.
  • SP1 was identified as a transcription factor that binds to the MIR181A2HG promoter, and its expression was positively correlated with MIR181A2HG. VCAN and CD44 signaling positively regulated SP1.

Limitations and Future Work

  • Specific Molecular Mechanisms of VCAN-CD44 Interaction: While the interaction between VCAN and CD44 was confirmed, the precise downstream molecular mechanisms initiated by this binding on GC cells and macrophages require further detailed investigation.
  • Therapeutic Strategy Design: The authors suggest MIR181A2HG-based targeted therapy as a novel strategy, but the specific design and preclinical validation of such therapies are not discussed.
  • Clinical Translation: Further research is needed to translate these findings into clinical applications, including the development of diagnostic biomarkers and therapeutic interventions.
  • Broader Impact of M2 Macrophages: While the study highlights M2 macrophage polarization, the broader implications of this polarization in the tumor microenvironment beyond lymphangiogenesis could be explored further.

Summary updated

Abstract

This study highlights the pivotal role of MIR181A2HG in GC progression and LNs metastasis. MIR181A2HG-based targeted therapy would represent a novel strategy for GC.
BibTeX
@inproceedings{zang2025scp,
  author = {Weijie Zang and Yongpu Yang and Junjie Chen and Qin‐Sheng Mao and Wanjiang Xue and Yilin Hu},
  title = {{The <scp>MIR181A2HG</scp>/<scp>miR</scp>‐5680/<scp>VCAN</scp>‐<scp>CD44</scp> Axis Regulates Gastric Cancer Lymph Node Metastasis by Promoting <scp>M2</scp> Macrophage Polarization}},
  booktitle = {Cancer},
  year = {2025},
  doi = {10.1002/cam4.70600},
}
Figure